Sarepta Therapeutics, Inc. 4
4 · Sarepta Therapeutics, Inc. · Filed Jan 15, 2014
Insider Transaction Report
Form 4
Krieg Arthur M
SVP, Chief Scientific Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2014-01-13+275,000→ 275,000 totalExercise: $20.08Exp: 2024-01-13→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]This option is exercisable at the rate of 25% of the shares on the first anniversary of hire and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on the fourth anniversary of hire.